Trends in General Acute Care Hospital Nurse Staffing From 2017 to 2022

The COVID-19 pandemic disrupted long-standing trends in the US nursing workforce. After years of steady growth, the number of registered nurses (RNs) in the workforce declined in 2021 but rebounded in 2022 and 2023. Faced with RN shortages, financial strain, and rising patient acuity, hospital leaders adopted alternative staffing models during the pandemic. These models…

Identifying Factors Associated With Variation in Telemental Health Delivery at Federally Qualified Health Centers

During the COVID-19 pandemic, telemental health—including video and phone visits—became essential for delivering mental healthcare as in-person visits declined and demand increased. Regulatory and payment changes at both federal and state levels in the US enabled its rapid expansion, with usage rising from under 1% pre-pandemic to 39% of behavioral health visits between March and…

Are DEA-waivered Buprenorphine Prescribers Co-located With Behavioral Health Clinicians?

Medication is increasingly used to treat opioid use disorder (OUD) in primary care. It incorporates medication (ie, buprenorphine) with behavioral therapy and/or psychosocial services. Targeted planning for co-location of DEA-waivered buprenorphine prescribers and behavioral health (BH) clinicians could increase the use of MOUD. Presently, less than half of all waivered prescribers, outside of hospitals, are…

Are DEA-Waivered Buprenorphine Prescribers Co-Located With Behavioral Health Clinicians?

Medication is increasingly used to treat opioid use disorder (OUD) in primary care. It incorporates medication (ie, buprenorphine) with behavioral therapy and/or psychosocial services. Targeted planning for co-location of DEA-waivered buprenorphine prescribers and behavioral health (BH) clinicians could increase the use of MOUD. Presently, less than half of all waivered prescribers, outside of hospitals, are…

Are DEA-Waivered Buprenorphine Prescribers Co-Located With Behavioral Health Clinicians?

Medication is increasingly used to treat opioid use disorder (OUD) in primary care. It incorporates medication (ie, buprenorphine) with behavioral therapy and/or psychosocial services. Targeted planning for co-location of DEA-waivered buprenorphine prescribers and behavioral health (BH) clinicians could increase the use of MOUD. Presently, less than half of all waivered prescribers, outside of hospitals, are…

Are DEA-waivered Buprenorphine Prescribers Co-located With Behavioral Health Clinicians?

Medication is increasingly used to treat opioid use disorder (OUD) in primary care. It incorporates medication (ie, buprenorphine) with behavioral therapy and/or psychosocial services. Targeted planning for co-location of DEA-waivered buprenorphine prescribers and behavioral health (BH) clinicians could increase the use of MOUD. Presently, less than half of all waivered prescribers, outside of hospitals, are…

    Want to stay up to date?

    Sign up for our mailing and never miss a new piece of information.

    I would like updates for:

    Filter Results

    Filter

    Filter Search Results